Using the miR-26 family as a predictive marker of hepatocellular carcinoma and sensitivity to therapy

摘要

A method for predicting clinical outcome of a patient who has been diagnosed hepatocellular carcinoma (HCC) comprising detecting the expression level of miR-26 in a sample of HCC tumor that haobtenido patient, wherein a decrease in 1.5 times or more the expression level of miR-26 in lamuestra tumor relative to a control predicts a decrease in survival, predicts respuestafavorable to therapy with interferon (IFN) -a, or both, in the the clinical outcome is a respuestafavorable to interferon therapy.